Vyome Holdings (HIND) FCF Margin (QoQ) (2016 - 2026)
Vyome Holdings (HIND) FCF Margin (QoQ) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.79 Bn | 131.94 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.74 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.48 Bn | 60.29 Bn | 1.37 Bn |
| 4 | Moderna | 59.32 Bn | 54.18 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.81 Bn | 28.50 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.56 Bn | 26.40 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - |
| 10 | Vyome Holdings | 16.00 Mn | 8.11 Mn | 11,658.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 119,282.00 |
| Mar 31, 2026 | -50,128.00 |
| Dec 31, 2025 | -1.66 Mn |
| Sep 30, 2025 | 1.31 Mn |
| Jun 30, 2025 | -41,357.00 |
| Mar 31, 2025 | -9,766.00 |
| Dec 31, 2024 | -333,852.00 |
| Sep 30, 2024 | 340,275.00 |
| Jun 30, 2024 | 3,753.00 |
| Mar 31, 2024 | 1,738.00 |
| Dec 31, 2023 | 374.00 |
| Sep 30, 2023 | 16,804.00 |
| Jun 30, 2023 | -7,414.00 |
| Mar 31, 2023 | -13,211.00 |
| Dec 31, 2022 | 10,051.00 |
| Sep 30, 2022 | 2,660.00 |
| Jun 30, 2022 | 8,607.00 |
| Sep 30, 2021 | -15,820.00 |
| Jun 30, 2021 | 1,490.00 |
| Mar 31, 2021 | -349.00 |